Drug Shortage Report for GD-LATANOPROST/TIMOLOL

Last updated on 2019-09-18 History
Report ID 91964
Drug Identification Number 02373068
Brand name GD-LATANOPROST/TIMOLOL
Common or Proper name GD/LATANOPROST/TIMOLOL
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Active Ingredient(s) TIMOLOL LATANOPROST
Strength(s) 5MG 50MCG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 2.5ml
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-22
Estimated end date 2019-09-20
Actual end date 2019-09-17
Shortage status Resolved
Updated date 2019-09-18
Company comments
Health Canada comments
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-09-18 French Compare
v7 2019-09-18 English Compare
v6 2019-08-23 English Compare
v5 2019-08-22 French Compare
v4 2019-08-22 English Compare
v3 2019-08-20 French Compare
v2 2019-08-20 French Compare
v1 2019-08-20 English Compare